Clinical Trial Update: Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of fenoterol metered-dose inhaler on beta-receptor populations on lymphocytes in patients with asthma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fenoterol Metered Dose Inhaler (fenoterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 3 | Status: TERMINATED